Every 10-Q that SS Innovations International Inc. (SSII) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow SSII and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SSII filings page.
SS Innovations International, Inc. reported strong top-line growth but continued losses for the three and six months ended June 30, 2026. Revenue for the quarter rose to $13.9 million from $10.0 million a year earlier, and six‑month revenue increased to $25.0 million from $15.1 million, driven mainly by higher system sales in India, which represented 93% of six‑month revenue.
Despite higher gross profit of $12.4 million for the first half, operating expenses grew to $18.3 million, including $5.3 million of stock‑based compensation and $3.4 million of research and development. The company posted a six‑month net loss of $6.2 million and total comprehensive loss of $8.2 million.
Liquidity improved after a March 2026 private placement that raised $18.4 million, contributing to cash, cash equivalents and restricted cash of $22.7 million at June 30, 2026 and a working capital surplus of $39.6 million. However, management states that existing cash and operating income are not expected to fund operations for the next 12 months, and explicitly notes substantial doubt about the company’s ability to continue as a going concern without additional financing or improved performance.
SS Innovations International, Inc. reported strong top-line growth but continued losses for the three months ended March 31, 2026. Revenue rose to $11,101,366 from $5,120,610 a year earlier, driven mainly by higher system sales.
The company posted a net loss of $3,582,571, improving from a $5,681,353 loss, with results heavily affected by non-cash stock compensation of $3,144,315 and depreciation of $323,747. Cash, cash equivalents and restricted cash increased to $24,005,680, helped by a private placement that generated net proceeds of $18,446,498.
Despite a working capital surplus of $40,216,514, management disclosed that recurring losses, dependence on related-party funding, and insufficient projected cash flows raise substantial doubt about the company’s ability to continue as a going concern over the next 12 months, absent additional financing and successful execution of growth plans.
SS Innovations International (SSII) filed its quarterly report and reported strong top-line growth with continued losses. Q3 revenue was $12.83M, up from $4.39M a year ago, driven by system sales. Gross profit rose to $6.16M from $2.32M. The company posted a Q3 net loss of $3.72M and a year‑to‑date net loss of $9.66M, an improvement from $17.23M in the prior‑year period.
As of September 30, 2025, total cash, cash equivalents and restricted cash were $12.04M; current cash and cash equivalents were $5.68M. Working capital showed a surplus of $27.24M. Operating cash outflow was $17.02M year‑to‑date, partly offset by $24.79M of net financing inflows, including issuance of $28.0M of one‑year 7% convertible notes and subsequent conversions totaling 21.86M shares. Inventory increased to $20.04M from $10.21M to support demand.
The company disclosed “substantial doubt” about its ability to continue as a going concern, citing ongoing losses and reliance on related‑party funding even after its April 2025 Nasdaq uplisting. During Q3, it sold 28 surgical robotic systems (55 year‑to‑date). Revenue was concentrated in India, which represented 94% of Q3 sales.
What happened: SS Innovations reported strong sales growth this quarter and in the first half of 2025, driven by system and instrument sales. Total revenue for the quarter was $10.0M and for the first six months $15.1M. Gross profit rose and operating results improved to a small positive operating income for the quarter, and the company completed an uplisting to NASDAQ.
Why it matters: The company boosted cash to $17.6M after financings and conversions, which helps near-term operations, but it still reported a $5.94M net loss for the first half and a small quarterly net loss after tax. Management discloses substantial doubt about the company’s ability to continue as a going concern and notes dependence on related-party financing and convertible note conversions.